Ben Messaoud Mejdi, Maatouk Mezri, Boussaada Mohamed Mehdi, Mahjoub Marouane, Mnari Walid, Gamra Habib
Cardiology A Department, Fattouma Bourguiba University Hospital, Monastir, Monastir, Monastir, 5000, Tunisia.
Radiology Department, Fattouma Bourguiba University Hospital, Monastir, Monastir, Monastir, 5000, Tunisia.
F1000Res. 2019 May 15;8:667. doi: 10.12688/f1000research.19041.1. eCollection 2019.
Heparin induced thrombocytopenia (HIT) is a rare but potentially life threatening adverse drug reaction. We report an unusual case of concomitant subacute coronary stent and femoral artery thrombosis secondary to HIT. In the current era of extensive growth of heparin use and percutaneous coronary interventions, it's important for clinicians to remember that such complication might occur and should be prevented.
肝素诱导的血小板减少症(HIT)是一种罕见但可能危及生命的药物不良反应。我们报告了一例因HIT继发亚急性冠状动脉支架和股动脉血栓形成的罕见病例。在当前肝素使用和经皮冠状动脉介入治疗广泛增加的时代,临床医生必须牢记可能会发生此类并发症并应加以预防。